DE3277694D1 - Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament - Google Patents

Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament

Info

Publication number
DE3277694D1
DE3277694D1 DE8282105523T DE3277694T DE3277694D1 DE 3277694 D1 DE3277694 D1 DE 3277694D1 DE 8282105523 T DE8282105523 T DE 8282105523T DE 3277694 T DE3277694 T DE 3277694T DE 3277694 D1 DE3277694 D1 DE 3277694D1
Authority
DE
Germany
Prior art keywords
alkoxy
halogen
substd
opt
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282105523T
Other languages
English (en)
Inventor
Kikuo Yasuda
Takayuki - Takezaki
Rikio Ohuchi
Hiroshi Ohuyabu
Yoshitaka Tanimoto
Toshimi Seki
Takashi Yamaguchi
Akihiro Izumi
Norio Himori
Tsutomu Ishimori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Teikoku Hormone Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Hormone Manufacturing Co Ltd filed Critical Teikoku Hormone Manufacturing Co Ltd
Application granted granted Critical
Publication of DE3277694D1 publication Critical patent/DE3277694D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8282105523T 1982-06-23 1982-06-23 Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament Expired DE3277694D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP82105523A EP0097202B1 (de) 1982-06-23 1982-06-23 Hydrazinopyridazinverbindung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
DE3277694D1 true DE3277694D1 (en) 1987-12-23

Family

ID=8189099

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282105523T Expired DE3277694D1 (en) 1982-06-23 1982-06-23 Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament

Country Status (3)

Country Link
EP (1) EP0097202B1 (de)
AT (1) ATE30911T1 (de)
DE (1) DE3277694D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711887A (en) * 1982-04-23 1987-12-08 Imperial Chemical Industries Plc Hydrazinopyridazine compounds
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
DE19616020A1 (de) * 1996-04-23 1997-10-30 Huels Chemische Werke Ag Neue Polyamine sowie ein Verfahren zu ihrer Herstellung
DE19956786A1 (de) * 1999-11-25 2001-05-31 Basf Ag Verfahren zur Herstellung optisch aktiver Amine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1016549A (en) * 1973-03-07 1977-08-30 Carlo Carpi Process for preparing anti-hypertensive 6-substituted 3-carbethoxyhydrazino-pyridazines
IT1165040B (it) * 1979-04-23 1987-04-22 Isf Spa Alcossialchilidenidrazinopiridazione e procedimento per la loro preparazione
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4711887A (en) * 1982-04-23 1987-12-08 Imperial Chemical Industries Plc Hydrazinopyridazine compounds

Also Published As

Publication number Publication date
EP0097202B1 (de) 1987-11-19
ATE30911T1 (de) 1987-12-15
EP0097202A1 (de) 1984-01-04

Similar Documents

Publication Publication Date Title
ATE115958T1 (de) Nukleoside und nukleosid-analoge, pharmazeutische zusammensetzung und verfahren für die herstellung der bestandteile.
RU95121639A (ru) Аза циклогексапептидные соединения
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
ES472817A1 (es) Un procedimiento para preparar analogos de tiadiazolil-cefa-losporina
MY108541A (en) Purine derivatives and use thereof in therapy.
ES553684A0 (es) Procedimiento para preparar derivados de amino-propanol
DE3277694D1 (en) Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament
MXPA04004532A (es) Medicamento para el tratamiento de enfermedades tumorales y virales de la piel.
ES442910A1 (es) Procedimiento de preparacion de sales de adicion con acidos minerales u organicos de derivados de piperidil-indol
MY104521A (en) Treatment of depression.
PT77364A (en) Process for preparing (1-arylcyclobutyl)-(heterocyclil)metthylamines active in particular but not exclusively as antidepressive therapeutic agents
SE7501985L (de)
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
IE821258L (en) Anti-herpes medicaments
IE38361L (en) Fish feed
ES523426A0 (es) Un metodo para preparar nuevos derivados de guanina
CA2143000A1 (en) Non-Metabolizable Clomiphene Analogs for Treatment of Tamoxifen-Resistant Tumors
DE3362260D1 (en) (-)-15-deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same
ZA864773B (en) 4-amino-2-(imidazolidin-2-on-1-yl)-5-(3-trifluoromethylphenylaminocarbonyl)pyrimidines for antithrombotic prophylaxis and treatment and their use for the preparation of medicaments having antithrombotic activity
IL124128A (en) Composition comprising a benzoylphenylurea for treatment of topical fungal infection
JPS5639019A (en) Antiviral agent
KR920011486A (ko) 항종양제
ES8506756A1 (es) Procedimiento para preparar derivados de afidicolina.
ES469206A1 (es) Un procedimiento para preparar acido 7 b-haloarilmalonamido-7-metoxi-3-tiometil heterociclico-1-destia-1-oxa-3-cefem-4- carboxilico
KR950703976A (ko) 아시클로비르 유사 화합물과 2′-비닐 치환 뉴클레오시드 유사체를 함유하는 바이러스 감염 치료용 조성물(Compositions Containing Acyclovir-Like Compounds and 2′-Vinyl substituted Nucleoside Analogs for the Treatment of Viral Infections)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee